Auxilium, GlaxoSmithKline sales and marketing update

Auxilium granted GlaxoSmithKline exclusive rights in the U.S. to co-promote testosterone replacement therapy Testim. Auxilium will book all sales of the topical 1% testosterone gel and pay GSK a percentage of net sales above an undisclosed baseline. GSK is expected to begin promoting Testim early next quarter. Auxilium will remain responsible for all manufacturing, supply and regulatory activities. The deal expires on Sept. 30, 2015. ...